CKM and neoplasm: Cancer cells exploit oxidative stress to drive DNA mutations and tumor progression; in brief, the Nrf2-Keap1 pathway regulates cellular antioxidant responses, but dysregulation leads to metabolic inflexibility and apoptotic resistance, exacerbating CKM-related metabolic dysfunction [103].